Pharma IQ, a Worldwide Leader in Pharmaceutical Conferences and Seminars, Launches the New "Global Discovery Outsourcing & Collaborations Forum 2010"

Online, June 3, 2010 (Newswire.com) - With an estimated 25% of R&D budgets now being spent on externalisation, it is crucial to develop strategic and effective business models and to determine how best to outsource the different processes of drug discovery and this is why the Global Discovery Outsourcing & Collaborations Form will play host to key figures in the pharma and bio industry.

With the involvement of 17 leading experts including Lubor Gaal, Head of Europe, Strategic Transactions Group, Bristol Myers-Squibb, Dr Iain Comley, Associate Director, Science & Technology Alliances, AstraZeneca and Dr Catherine Tralau, Head of Drug Discovery Facility& Pharmacology, Imperial College London, the Global Discovery Outsourcing and Collaborations Forum will offer the opportunity to discover new approaches to forming drug discovery partnerships and collaborating with a range of different organisations that will result in more efficient and cost-effective discovery.

The event will also promote growth and innovation through implementing a virtual Pharma model with case studies from Sophie Hallakou-Bozec, Research Director and Cofounder, Poxel, Dr Stephen Shuttleworth, CSO, Karus Therapeutics.

For a full overview of the topics that will be discussed during the forum, the full list of speakers, information about the pre-conference workshops and free online resources please visit www.GlobalDiscoveryCollaborations.com

About Us:
IQPC Ltd - IQPC has an established reputation for delivering the highest standard of industry specific conferences, seminars and internal training programmes. We aim to keep business executives up-to date with the forefront of their industries' trends, technological developments and regulatory landscape.

For any more information please call +44 (0)20 7368 9300 or email [email protected]